Octant

Octant is a data-driven biopharmaceutical company developing programmable biology and chemistry to create precision medicines for complex diseases. Guided by extensive proprietary datasets, Octant designs drugs with novel mechanisms of action, uncovering insights into the relationships between genomes, drug candidates, biochemical functions, and disease phenotypes in engineered human cells. Founded in 2017, its platform integrates four key technologies—synthetic biology, high-throughput multiplex assays, synthetic chemistry, and computational methods—to design and study drugs, proteins, and cellular pathways, aiming for safer, more effective, and more affordable medicines.